IT vs MIST · P/E 16, rev $6.27B vs $160.6M cap
Gartner Inc (IT) versus Milestone Pharmaceuticals Inc (MIST) — a side-by-side from cached financials, not a winner call.
Gartner Inc (IT) is a information technology services company listed on US.
Milestone Pharmaceuticals Inc (MIST) is a biotechnology company listed on US.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
MIST does not have a complete income-statement cache yet.
IT currently screens at market cap $11.03B and trailing P/E 16.3. MIST currently screens at market cap $160.6M.
Not investment advice. Open the IT and MIST stock pages for the full models.
Not investment advice.